+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Medical Imaging Phantoms Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 197 Pages
  • November 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968676
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medical imaging phantoms are reshaping diagnostic confidence and operational efficiency as healthcare leaders prepare for regulatory changes and rapid advancements in imaging technologies. These precise simulation tools ensure healthcare executives can raise standards, manage compliance, and futureproof infrastructure in a highly competitive market.

Market Snapshot: Medical Imaging Phantoms Market Overview

The medical imaging phantoms market is demonstrating continued, steady growth, fuelled by widening adoption of advanced imaging systems across healthcare settings.

Medical imaging phantoms—engineered to closely represent human anatomy—enable accurate calibration across MRI, CT, PET, X-ray, nuclear, and ultrasound platforms. They play an essential role in regulatory adherence, operational risk mitigation, and upskilling of clinical personnel. From provider organizations to research entities, these tools are supporting workflow consistency and enabling a seamless shift toward digital and AI-enabled imaging standards.

Scope & Segmentation

This report offers senior decision-makers a comprehensive analysis to inform resource planning and technology investment, with segmentation across key domains:

  • Product Types: Includes CT, MRI, nuclear imaging, PET, ultrasound, and X-ray phantoms, suitable for both clinical routines and research-driven development.
  • Material Types: Solutions utilize acrylic, epoxy, hydrogel, plastic, and rubber, supporting diverse needs in simulation realism, equipment performance validation, and regulatory calibration.
  • Applications: Applied in quality assurance, device evaluation, both clinical and preclinical studies, and for specialized training within medical and academic institutions.
  • End Users: Academic organizations, research institutes, diagnostics laboratories, hospitals, and pharmaceutical firms drive demand, prioritizing measurement consistency and regulatory alignment.
  • Regions: Evaluates the Americas, Europe, Middle East & Africa, and Asia-Pacific, capturing varying readiness levels, regional compliance conditions, and drivers of technology investment.
  • Representative Countries: Detailed focus on the United States, United Kingdom, Germany, China, Japan, Brazil, and South Africa uncovers adoption approaches and regional solution preferences.
  • Leading Companies: Analysis of Computerized Imaging Reference Systems, Sun Nuclear Corporation, Standard Imaging, Kyoto Kagaku, and additional leading international suppliers for benchmarking solution portfolios and market roles.

Understanding these segments enables executives to prioritize growth opportunities, recalibrate internal standards, and optimize strategic partnerships in line with shifting healthcare and regulatory trends.

Key Takeaways

  • As modernization efforts accelerate, medical imaging phantoms remain central for training excellence, process optimization, and alignment with regulatory frameworks.
  • Technological advances—particularly in additive manufacturing—improve anatomical fidelity, which strengthens simulation for advanced imaging evaluation and protocol standardization.
  • Reliable phantom calibration contributes to professional development and ensures protocols remain robust across diverse care settings.
  • Expansion of digital phantom platforms allows flexible remote training and supports integration with AI diagnostics, enhancing organizational readiness for future workflows.
  • Regional procurement strategies evolve, with mature markets focusing on efficiency and compliance, while growth regions emphasize adaptable solutions that fit specific infrastructure and budget realities.

Tariff Impact: Navigating the 2025 United States Tariff Environment

New United States tariff measures have shifted purchasing strategies for imaging phantom solutions. Organizations are responding by broadening supplier networks, building domestic manufacturing collaborations, and leveraging nearshoring to reinforce supply stability and reduce exposure to policy changes.

Methodology & Data Sources

The findings are based on direct interviews with industry leaders, procurement specialists, and imaging professionals. Supplementary analysis draws from peer-reviewed scientific literature, current regulatory references, and validated industry intelligence, resulting in an objective foundation for executive decision-making.

Medical Imaging Phantoms Market: Why This Report Matters

  • Equips senior leaders with actionable insights for setting priorities, allocating resources, and accelerating strategic initiatives across core user groups and regions.
  • Delivers clarity on quality processes, providing decision-makers with practical guidance for mitigating risk and integrating cutting-edge digital assessment tools within compliance frameworks.
  • Facilitates efficient navigation through the evolving landscape of innovation, compliance, and market opportunity—enabling organizations to align their imaging practices with changing healthcare demands.

Conclusion

This report provides a clear pathway for senior executives to address investment priorities, compliance requirements, and technology transitions in a dynamic market, supporting continued organizational excellence and resilience in diagnostic imaging.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rising adoption of patient-specific 3D printed phantoms for personalized radiation therapy quality assurance
5.2. Increasing integration of artificial intelligence-driven imaging phantoms to standardize CT and MRI performance metrics
5.3. Development of multimodal imaging phantoms compatible with MRI, CT, ultrasound and PET for comprehensive scanner calibration
5.4. Growing demand for anthropomorphic phantoms simulating pediatric anatomies to optimize dose management in pediatric imaging
5.5. Advancements in biomimetic tissue-equivalent materials for high fidelity ultrasound and elastography phantom construction
5.6. Expansion of virtual and digital phantom platforms for image reconstruction algorithm validation and clinical workflow training
5.7. Collaboration between academic research institutions and manufacturers to design customizable phantoms for novel modality testing
5.8. Regulatory emphasis on standardized phantom-based quality control protocols to ensure reproducible imaging performance across facilities
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Medical Imaging Phantoms Market, by Product Type
8.1. CT Phantom
8.2. MRI Phantom
8.3. Nuclear Imaging Phantom
8.4. Pet Phantom
8.5. Ultrasound Phantom
8.6. X-Ray Phantom
9. Medical Imaging Phantoms Market, by Material
9.1. Acrylic
9.2. Epoxy
9.3. Hydrogel
9.4. Plastic
9.5. Rubber
10. Medical Imaging Phantoms Market, by Application
10.1. Equipment Testing
10.2. Quality Assurance
10.3. Research
10.4. Training & Education
11. Medical Imaging Phantoms Market, by End User
11.1. Academic & Research Institutes
11.2. Diagnostic Centers
11.3. Hospitals
11.4. Pharmaceutical Companies
12. Medical Imaging Phantoms Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Medical Imaging Phantoms Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Medical Imaging Phantoms Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Computerized Imaging Reference Systems, Inc.
15.3.2. Sun Nuclear Corporation
15.3.3. Standard Imaging, Inc.
15.3.4. Kyoto Kagaku Co., Ltd.
15.3.5. Modus Medical Devices Inc.
15.3.6. PTW-Freiburg GmbH
15.3.7. Phantom Laboratory, Inc.
15.3.8. Tissue Simulation Technology, LLC
15.3.9. Radiation Imaging Technology, Inc.
15.3.10. Fluke Biomedical

Companies Mentioned

The companies profiled in this Medical Imaging Phantoms market report include:
  • Computerized Imaging Reference Systems, Inc.
  • Sun Nuclear Corporation
  • Standard Imaging, Inc.
  • Kyoto Kagaku Co., Ltd.
  • Modus Medical Devices Inc.
  • PTW-Freiburg GmbH
  • Phantom Laboratory, Inc.
  • Tissue Simulation Technology, LLC
  • Radiation Imaging Technology, Inc.
  • Fluke Biomedical

Table Information